Clinical Trial Update: Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

View source ↗

Summary

This clinical trial update discusses using thrombotic biomarkers to predict thrombosis risk in patients with heparin-induced thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia
• Thrombosis

Snippet

Sponsor: Wuhan Asia Heart Hospital | Conditions: Heparin-Induced Thrombocytopenia, Thrombosis | Status: UNKNOWN